Speakers

Alessio Ciulli

Professor of Structural Chemical Biology

University of Dundee

Georg Winter

Principal Investigator

CeMM Research Centre for Molecular Medicine

Raj Chopra

Director of Cancer Research UK Cancer Therapeutics Unit; Head of Division of Cancer Therapeutics

The Institute of Cancer Research

Brian Jones

Chief Scientific Officer

Cedilla Therapeutics

John Harling

Senior Scientific Director of Medicinal Chemistry

GlaxoSmithKline

Piergiorgio Pettazzoni

Senior Scientist & Lab Head

Roche

Laura Itzhaki

Professor, University of Cambridge; Chief Scientific Officer

PolyProx Therapeutics

Nello Mainolfi

Founder, President & Chief Scientific Officer

Kymera Therapeutics

Paul Thompson

Vice President of Clinical Development

Mission Therapeutics

Davide Gianni

Associate Director of Genomics

AstraZeneca

Derek Bartlett

Senior Principal Scientist

Pfizer

Joerg Rinnenthal

Principal Scientist

Boehringer Ingelheim

Bomie Han

Research Advisor

Eli Lilly

Gopal Sapkota

Principal Investigator

University of Dundee

Simon Bailey

Executive Vice President & Head of Drug Discovery

Plexium

Diala Ezzeddine

Chief Executive Officer

Xios Therapeutics

Josh Hansen

Director of Chemistry

Celgene

Terry Rabbitts

Professor of Molecular Immunology

Weatherall Institute of Molecular Medicine; University of Oxford; The Institute of Cancer Research

David Rubinsztein

Professor of Molecular Neurogenetics & UK Dementia Research Institute

University of Cambridge

Ivan Dikic

Director of Institute of Biochemistry II

Goethe University Frankfurt

Markus Muellner

Chief Technology Officer

Phoremost

Danette Daniels

Group Leader of Functional Proteomics

Promega

Jin Li

Chairman & Chief Executive Officer

HitGen

Laura Luh

Research Scientist

Bayer AG

Agustina Rodriguez-Granillo

Principal Scientist II

Schrodinger

Randy Teel

Vice President of Corporate Development

Arvinas

Tom Coulter

Director of Integrated Drug Discovery

Selvita